InflaRx has reported its Q2 2025 results and provided updates [...]

New research from Pioneer Group, in collaboration with Beauhurst, reveals [...]

DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]

Appointments reflect strategic focus on infectious disease and medical affairs [...]

Appointment strengthens expertise in targeted protein degradation as company advances [...]

Gesynta Pharma has announced the second closing of its Series [...]

Solvias has achieved Current Good Manufacturing Practice (cGMP) readiness at [...]

One Biosciences, a precision oncology techbio company specialising in clinical-grade [...]

Cereno Scientific, a biotechnology company pioneering treatments for rare cardiovascular [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]